- Home
- NAVN vs LEGN Comparison
NAVN vs LEGN Comparison
Compare NAVN & LEGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NAVN
- LEGN
- Stock Information
- Founded
- NAVN 2015
- LEGN 2014
- Country
- NAVN United States
- LEGN United States
- Employees
- NAVN N/A
- LEGN N/A
- Industry
- NAVN Computer Software: Prepackaged Software
- LEGN Biotechnology: Pharmaceutical Preparations
- Sector
- NAVN Technology
- LEGN Health Care
- Exchange
- NAVN Nasdaq
- LEGN Nasdaq
- Market Cap
- NAVN 5.3B
- LEGN 6.3B
- IPO Year
- NAVN 2025
- LEGN 2020
- Fundamental
- Price
- NAVN $18.86
- LEGN $32.02
- Analyst Decision
- NAVN
- LEGN Strong Buy
- Analyst Count
- NAVN 0
- LEGN 12
- Target Price
- NAVN N/A
- LEGN $70.82
- AVG Volume (30 Days)
- NAVN 8.5M
- LEGN 1.4M
- Earning Date
- NAVN 01-01-0001
- LEGN 11-12-2025
- Dividend Yield
- NAVN N/A
- LEGN N/A
- EPS Growth
- NAVN N/A
- LEGN N/A
- EPS
- NAVN N/A
- LEGN N/A
- Revenue
- NAVN $612,523,000.00
- LEGN $796,838,000.00
- Revenue This Year
- NAVN N/A
- LEGN $68.68
- Revenue Next Year
- NAVN N/A
- LEGN $48.49
- P/E Ratio
- NAVN N/A
- LEGN N/A
- Revenue Growth
- NAVN 33.46
- LEGN 74.75
- 52 Week Low
- NAVN $16.01
- LEGN $27.34
- 52 Week High
- NAVN $22.75
- LEGN $47.79
- Technical
- Relative Strength Index (RSI)
- NAVN N/A
- LEGN 44.29
- Support Level
- NAVN N/A
- LEGN $31.60
- Resistance Level
- NAVN N/A
- LEGN $33.39
- Average True Range (ATR)
- NAVN 0.00
- LEGN 1.15
- MACD
- NAVN 0.00
- LEGN 0.08
- Stochastic Oscillator
- NAVN 0.00
- LEGN 17.90
About LEGN Legend Biotech Corporation
Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.